Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice

Zhao, Liang-Yun; Mao, Xiao-Peng; Chao, Kai-Yuan; Guo, Sheng-Jie; Qiu, Shao-Peng.
Braz. j. med. biol. res ; 45(8): 737-745, Aug. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-643650

Documentos relacionados

  1. Discovery of PSMA in the prostate of the common marmoset (Callithrix jacchus).
  2. The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer.
  3. First-in-human study of PSMA-targeting agent, [<sup>18</sup>F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.
  4. <sup>68</sup>Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent.
  5. PSMA-Targeting Imaging and Theranostic Agents-Current Status and Future Perspective.
  6. Palladium-Mediated <i>S</i>-Arylation of Cysteine Residues with 4-[<sup>18</sup>F]Fluoroiodobenzene ([<sup>18</sup>F]FIB).
  7. A PSMA-targeted doxorubicin small-molecule drug conjugate.
  8. Automatic radiosynthesis and preclinical evaluation of <sup>18</sup>F-AlF-PSMA-NF as a potential PET probe for prostate cancer imaging.
  9. Development of [<sup>177</sup>Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.
  10. Preclinical Evaluation of a Novel High-Affinity Radioligand [<sup>99m</sup>Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA).